Arianna Johnson, Forbes Staff

Author's posts

More People Got Diabetes During The Covid Pandemic—Here’s Why

Over 37 million Americans have diabetes, including over 280,000 adolescents under the age of 20.

Fungal Meningitis Outbreak In Mexico Kills 2 After Cosmetic Surgeries. Here’s What We Know—And Symptoms And Treatment.

Mexico is the most popular destination for American medical tourists, accounting for 41% of all visits.

Ozempic As A Pill: Drug Makers Race For Cheaper Weight Loss Drugs (Without The Shots)

Over 69% of Americans are either overweight or obese, so new oral weight loss medications have the potential to decrease this statistic.

New Studies Find Covid Vaccines Are Safe For Kids: Here Are The Different Types Of Vaccines—And How They Work

Despite being available for well over a year, many children are not vaccinated against Covid-19.

Worrisome BPA Levels Found In Sportswear By Nike, Adidas, Patagonia And More, Group Alleges

The group previously pursued legal action against other sportswear companies including The North Face and Pink for similar findings.

Worrisome BPA Levels Found In Sportswear By Nike, Adidas, Patagonia And More, Group Alleges

The group previously pursued legal action against other sportswear companies including The North Face and Pink for similar findings.

Covid’s No Longer A Public Health Emergency: Here’s How That May Affect You

Millions of Americans may have to pay out-of-pocket for vaccines, tests and treatments once they’re no longer federally supplied.

Wegovy Shortage: Drug Maker Limits Distribution—Here’s When Supplies Should Improve

Patients taking Wegovy typically see a 14.9% decrease in body weight after 68 weeks.

What To Know About ‘Arcturus’: New Covid Variant Causing Pink Eye

Arcturus (or XBB.1.16) is the second most prevalent subvariant, making up 9.6% of all U.S. Covid cases.

Weight Loss Drug Saxenda May Make WHO List: Could Help Make It Cheaper Worldwide

Liraglutide has been approved for weight loss since 2014 by the FDA.